Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||
| Net Income | -24,336 | -29,485 |
| Depreciation Amortization | 596 | 1,037 |
| Accounts payable and accrued liabilities | -319 | N/A |
| Other Working Capital | 1,599 | 1,895 |
| Other Operating Activity | -821 | -3,913 |
| Operating Cash Flow | $-23,281 | $-30,466 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -182 | -1,773 |
| Investing Cash Flow | $-182 | $-1,773 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -155 | N/A |
| Common Stock Issued | 2 | N/A |
| Other Financing Activity | 0 | 62,190 |
| Financing Cash Flow | $-153 | $62,190 |
| Beginning Cash Position | 66,090 | 36,139 |
| End Cash Position | 42,474 | 66,090 |
| Net Cash Flow | $-23,616 | $29,951 |
| Free Cash Flow | ||
| Operating Cash Flow | -23,281 | -30,466 |
| Capital Expenditure | -182 | N/A |
| Free Cash Flow | -23,463 | -30,466 |